1. According to an article published by Xinhua news agency, the financial commission of the State Council took action at the critical moment, which boosted market confidence. At present, both the increasing downward pressure on China's economy and the increasingly complex international environment have put forward higher requirements for monetary policy. China's monetary policy should not only adhere to the principle of "focusing on myself", but also "make efforts ahead", take the initiative, do things quickly, operate prospectively, walk in front of the market curve and guide expectations. In terms of real estate, there are broken and established. On the one hand, we should prevent and resolve risks, on the other hand, we should actively introduce supporting policies to promote the transformation of the real estate industry to a new development model.
2. According to the economic information daily, in the past week, several financial regulatory departments have made statements one after another, the signals of stable growth and stable expectation have been intensively released, and the policies of financial support entities have been strengthened in an all-round way. Looking forward to the future, monetary policy will take the initiative, and it is necessary and possible to cut interest rates and reserve requirements. While ensuring the overall moderate growth of bank credit, the regulatory authorities will also further guide the flow of funds into key areas and weak links such as small and micro enterprises and scientific and technological innovation.
3. The press conference of the joint prevention and control mechanism of the State Council said that the local epidemic in China is still in the development stage, and many provinces are facing the prevention and control situation of Omicron epidemic in many regions and cities at the same time. The current round of epidemic is dominated by light and asymptomatic infections, accounting for more than 95%. The existing vaccination and booster vaccination are still effective for the Omicron variant; Some Omicron variant vaccines have completed preclinical research and are submitting application materials for clinical trials.
